Series A specialty pharmaceutical company focused on providing oncology and immunology therapies across South Asia.

• Guided market entry and expansion strategies across South Asian healthcare markets.

• Facilitated licensing partnerships with global biotech and pharmaceutical companies.

• Advised on fundraising efforts to support idea to growth-stage scaling (pre-seed to series A) and product portfolio expansion.

• Supported commercial strategy to drive adoption of oncology and immunology therapies in underserved markets.